These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 19607816)

  • 1. SP600125, an inhibitor of Jnk pathway, reduces viability of relatively resistant cancer cells to doxorubicin.
    Kim JH; Kim TH; Kang HS; Ro J; Kim HS; Yoon S
    Biochem Biophys Res Commun; 2009 Sep; 387(3):450-5. PubMed ID: 19607816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jnk signaling pathway-mediated regulation of Stat3 activation is linked to the development of doxorubicin resistance in cancer cell lines.
    Kim JH; Lee SC; Ro J; Kang HS; Kim HS; Yoon S
    Biochem Pharmacol; 2010 Feb; 79(3):373-80. PubMed ID: 19766599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway.
    Shinoda C; Maruyama M; Fujishita T; Dohkan J; Oda H; Shinoda K; Yamada T; Miyabayashi K; Hayashi R; Kawagishi Y; Fujita T; Matsui S; Sugiyama E; Muraguchi A; Kobayashi M
    Int J Cancer; 2005 Oct; 117(1):21-31. PubMed ID: 15880572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential role of c-Jun-NH2-terminal kinase on synergy induction of apoptosis by TRAIL plus ADM in ADM resistant MCF-7/ADM cells.
    Li F; Meng L; Xing H; Zhou J; Wang S; Huang L; Xu G; Zhu H; Lu Y; Ma D
    Apoptosis; 2006 Jul; 11(7):1239-46. PubMed ID: 16703262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of c-Jun N-terminal kinase sensitizes tumor cells to flavonoid-induced apoptosis through down-regulation of JunD.
    Kook SH; Son YO; Jang YS; Lee KY; Lee SA; Kim BS; Lee HJ; Lee JC
    Toxicol Appl Pharmacol; 2008 Mar; 227(3):468-76. PubMed ID: 18078968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conflicting evidence for the role of JNK as a target in breast cancer cell proliferation: Comparisons between pharmacological inhibition and selective shRNA knockdown approaches.
    Wood RA; Barbour MJ; Gould GW; Cunningham MR; Plevin RJ
    Pharmacol Res Perspect; 2018 Feb; 6(1):. PubMed ID: 29417765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transduction pathways in Burkitt's lymphoma cell lines BL41 and DG75 with different sensitivity to doxorubicin.
    Shlapatska LM; Berdova GG; Kovalevska LM; Kulyk GI; Klein G; Sidorenko SP; Chekhun VF
    Exp Oncol; 2004 Sep; 26(3):210-6. PubMed ID: 15494689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-generation proteasome inhibitor carfilzomib enhances doxorubicin-induced cytotoxicity and apoptosis in breast cancer cells.
    Shi Y; Yu Y; Wang Z; Wang H; Bieerkehazhi S; Zhao Y; Suzuk L; Zhang H
    Oncotarget; 2016 Nov; 7(45):73697-73710. PubMed ID: 27655642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance.
    Zeng X; Morgenstern R; Nyström AM
    Biomaterials; 2014 Jan; 35(4):1227-39. PubMed ID: 24210875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
    Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JNK supports survival in melanoma cells by controlling cell cycle arrest and apoptosis.
    Alexaki VI; Javelaud D; Mauviel A
    Pigment Cell Melanoma Res; 2008 Aug; 21(4):429-38. PubMed ID: 18541008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Jun N-terminal kinase activity supports multiple phases of 3D-mammary epithelial acinus formation.
    McNally S; McArdle E; Gilligan E; Napoletano S; Gajewska M; Bergin O; McCarthy S; Whyte J; Bianchi A; Stack J; Martin F
    Int J Dev Biol; 2011; 55(7-9):731-44. PubMed ID: 22161830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JNK is required for maintaining the tumor-initiating cell-like properties of acquired chemoresistant human cancer cells.
    Liu Y; Zhang X; Wang J; Yang J; Tan WF
    Acta Pharmacol Sin; 2015 Sep; 36(9):1099-106. PubMed ID: 26235742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib--the role of extracellular signal-regulated kinase counteraction.
    Manov I; Pollak Y; Broneshter R; Iancu TC
    FEBS J; 2011 Sep; 278(18):3494-507. PubMed ID: 21790999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels.
    Nestal de Moraes G; Vasconcelos FC; Delbue D; Mognol GP; Sternberg C; Viola JP; Maia RC
    Eur J Cell Biol; 2013; 92(8-9):247-56. PubMed ID: 24064045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BME, a novel compound of anthraquinone, down regulated P-glycoprotein expression in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells via generation of reactive oxygen species.
    Wang J; Liu L; Cen J; Ji B
    Chem Biol Interact; 2015 Sep; 239():139-45. PubMed ID: 26169035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective targeting of FAK-Pyk2 axis by alpha-naphthoflavone abrogates doxorubicin resistance in breast cancer cells.
    Datta A; Bhasin N; Kim H; Ranjan M; Rider B; Abd Elmageed ZY; Mondal D; Agrawal KC; Abdel-Mageed AB
    Cancer Lett; 2015 Jun; 362(1):25-35. PubMed ID: 25796439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COX-2 inhibitor NS-398 suppresses doxorubicin-induced p53 accumulation through inhibition of ROS-mediated Jnk activation.
    Kim J; Shim M
    Mol Carcinog; 2016 Dec; 55(12):2156-2167. PubMed ID: 26756900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of HMGB1 in doxorubicin-induced myocardial apoptosis and its regulation pathway.
    Yao Y; Xu X; Zhang G; Zhang Y; Qian W; Rui T
    Basic Res Cardiol; 2012 May; 107(3):267. PubMed ID: 22527657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylinositol- 3-kinase inhibitor induces chemosensitivity to a novel derivative of doxorubicin, AD198 chemotherapy in human bladder cancer cells in vitro.
    Smolensky D; Rathore K; Cekanova M
    BMC Cancer; 2015 Nov; 15():927. PubMed ID: 26597249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.